The Genesis of Allogenic Inlays

Are allogenic corneal inlays becoming a feasible option for refractive correction?

By Ruth Steer

August 2016

At a Glance

  • As the number of people with presbyopia continues to increase, so too does the size of this potentially lucrative market
  • Corneal inlays are a proven method of presbyopia correction, and a number are commercially available today
  • All, however, use synthetic materials, which hold a small risk of biocompatibility issues
  • To avoid those issues, allogenic inlays that utilize donor human corneal tissue, which would have otherwise been wasted, are currently under investigation

Refractive surgery is a mostly elective, and therefore relatively lucrative market. As such, there has been a big focus on technological innovation in the field, and the last decade has seen great advances made in laser refractive surgery, clear lens exchange, and phakic IOL design. Thanks to the demographic bulge that is the baby boomer generation, the customer base is only likely to increase, with presbyopes representing the largest potential market for refractive correction. It’s precisely for this indication that corneal inlays have been – and are being – developed.